Testing how well Lembas Edge controls blood sugar after meals
Part of Hormones & metabolism clinical trials.
This study tests a new product called Lembas Edge to see how well it controls blood sugar after eating. Part 2 of the study is for people with prediabetes (blood sugar higher than normal but not yet diabetes) and a body mass index (BMI) in the overweight to obese range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- For Part 1, you should be healthy overall. For Part 2, you should have a BMI between 25 and 34.9 (overweight to obese) and blood sugar levels that suggest prediabetes.
- You cannot have type 1 or type 2 diabetes.
- You must agree to use birth control if you could become pregnant, and not be pregnant or planning pregnancy.
- You should be willing to keep your usual diet, activity, and medications stable during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational product to see how well it controls blood sugar in adults with prediabetes or type 2 diabetes. Some participants will also take the diabetes medication semaglutide to compare effects.
This trial tests whether the Golo for Life plan (with a release supplement) can improve blood sugar and help with weight in adults who have prediabetes or type 2 diabetes. If you join, you’ll follow the program and attend clinic visits while your health, diet, and weight are tracked.
This study tests whether a nutritional supplement called Nextida GC-B helps control blood sugar in people who either have normal blood sugar or prediabetes. It looks at how the supplement affects blood sugar levels over time using a continuous glucose monitor.
This trial tests whether a special GLP-1 formula drink can help control blood sugar and improve gut bacteria in people with prediabetes. It may offer a new way to manage early diabetes risk.
This study tests a supplement made from legume seed coats that may help control blood sugar. It is open to healthy adults, people at risk for diabetes, or those already diagnosed with type 2 diabetes.
This study looks at how your genes may change how well a GLP-1–type medicine works to improve prediabetes. It focuses on adults at higher risk of developing diabetes, especially people of Mexican-American background.
Hear when a new Postprandial Glycemic Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.